Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
書誌事項
- 公開日
- 2019-11-12
- 資源種別
- journal article
- 権利情報
-
- https://creativecommons.org/licenses/by/4.0/
- DOI
-
- 10.3389/fonc.2019.01219
- 10.5167/uzh-181373
- 公開者
- Frontiers Media SA
説明
Metastatic non-small cell lung cancer (NSCLC) is associated with a limited survival when treated with palliative intent platinum-based chemotherapy alone. Recent advances in imaging and therapeutic strategy have identified a subset of patients with limited metastases who may benefit from early local ablative therapy with either surgery or radiotherapy, in addition to standard treatment. Stereotactic body radiotherapy (SBRT) is increasingly used in the treatment of extra-cranial oligometastatic NSCLC (OM-NSCLC) due its non-invasive conduct and ability to deliver high doses. Clinical evidence supporting the use of SBRT in OM-NSCLC is emerging and consistently demonstrates significant benefit in local control and progression-free survival. Here, we discuss the definition of oligometastases (OM), review current available data on SBRT treatment in extra-cranial OM-NSCLC including evidence for site-specific SBRT in lung, liver, and adrenal metastases.
収録刊行物
-
- Frontiers in Oncology
-
Frontiers in Oncology 9 2019-11-12
Frontiers Media SA
- Tweet
キーワード
- Cancer Research
- 610
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
- 610 Medicine & health
- oligometastatic disease
- 10044 Clinic for Radiation Oncology
- oligometastases
- lung cancer
- stereotactic body radiotherapy
- Oncology
- 2730 Oncology
- 1306 Cancer Research
- non-small cell lung cancer
- RC254-282
詳細情報 詳細情報について
-
- CRID
- 1362539019057742976
-
- ISSN
- 2234943X
-
- HANDLE
- 11343/247127
-
- PubMed
- 31799188
-
- 資料種別
- journal article
-
- データソース種別
-
- Crossref
- KAKEN
- OpenAIRE